Systemic administration of polymeric nanoparticle-encapsulated curcumin (NanoCurc) blocks tumor growth and metastases in preclinical models of pancreatic cancer. [electronic resource]
Producer: 20101126Description: 2255-64 p. digitalISSN:- 1538-8514
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Biological Availability
- Cell Line, Tumor
- Cell Proliferation -- drug effects
- Curcumin -- administration & dosage
- Cyclin D1 -- metabolism
- Deoxycytidine -- analogs & derivatives
- Disease Models, Animal
- Down-Regulation -- drug effects
- Drug Synergism
- Humans
- Matrix Metalloproteinase 9 -- metabolism
- Mice
- NF-kappa B -- metabolism
- Nanoparticles -- administration & dosage
- Neoplasm Metastasis -- pathology
- Pancreatic Neoplasms -- drug therapy
- Polymers -- administration & dosage
- Subcutaneous Tissue -- drug effects
- Xenograft Model Antitumor Assays
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.